How Fe3+ binds anthracycline antitumour compounds. The myth and the reality of a chemical sphinx (Q78138098)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450605%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

title

How Fe3+ binds anthracycline antitumour compounds. The myth and the reality of a chemical sphinx (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450605%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

author name string

M M Fiallo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450605%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

A Garnier-Suillerot

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450605%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

B Matzanke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450605%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

H Kozlowski

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450605%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450605%20AND%20SRC:MED&resulttype=core&format=json

Journal of Inorganic Biochemistry

11 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450605%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450605%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450605%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

page(s)

105-115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450605%20AND%20SRC:MED&resulttype=core&format=json

Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol

11 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Quelamycin, a new derivative of adriamycin with several possible therapeutic advantages

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Iron(III)-adriamycin and Iron(III)-daunorubicin complexes: physicochemical characteristics, interaction with DNA, and antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Physicochemical studies of the iron(III)-carminomycin complex and evidence of the lack of stimulated superoxide production by NADH dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Interaction of 5-iminodaunorubicin with Fe(III) and with cardiolipin-containing vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Physicochemical characteristics of ferric adriamycin complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Evidence for polynuclear aggregates of ferric daunomycin. A Mössbauer, EPR, X-ray absorption spectroscopy and magnetic susceptibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Time-dependent modifications of ferric-adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Transport of an iron: anthracycline complex by murine leukemia cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Interactions of iron-anthracycline complexes with living cells: a microspectrofluorometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Iron-mediated formation of an oxidized adriamycin free radical

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Inhibition and inactivation of NADH-cytochrome c reductase activity of bovine heart submitochondrial particles by the iron(III)-adriamycin complex

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

The iron(III)-adriamycin complex inhibits cytochrome c oxidase before its inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Adriamycin and its iron(III) and copper(II) complexes. Glutathione-induced dissociation; cytochrome c oxidase inactivation and protection; binding to cardiolipin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Oxidative destruction of DNA by the adriamycin-iron complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Role of daunosamine and hydroxyacetyl side chain in reaction with iron and lipid peroxidation by anthracyclines.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Degradation of anthracycline antitumor compounds catalysed by metal ions

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Accumulation of degradation products of doxorubicin and pirarubicin formed in cell culture medium within sensitive and resistant cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Circular dichroism studies on anthracycline antitumor compounds. Relationship between the molecular structure and the spectroscopic data

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Expression of the multidrug resistance, MDR1, gene in neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles. Circular dichroism study

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Metal anthracycline complexes as a new class of anthracycline derivatives. Pd(II)-adriamycin and Pd(II)-daunorubicin complexes: physicochemical characteristics and antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Bifunctional antitumor compounds: interaction of adriamycin with metallocene dichlorides

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

Characterization of adriamycin-resistant and radiation-sensitive Chinese hamster cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

An enhanced ability for transforming adriamycin into a noncytotoxic form in a multidrug-resistant cell line (LZ-8)

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900040-9

7 January 2021

10.1016/S0162-0134(99)00040-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450605%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference